Trondsen E, Edwin B, Reiertsen O, Faerden A E, Fagertun H, Rosseland A R
Department of Surgical Gastroenterology, Central Hospital of Akershus, Nordbyhagen, Norway.
Arch Surg. 1998 Feb;133(2):162-6. doi: 10.1001/archsurg.133.2.162.
Selection routines for preoperative endoscopic retrograde cholangiopancreatography (ERCP) in patients with symptomatic gallstone disease should give a low frequency of both false-negative ERCP results and residual common bile duct stones (CBDS).
To validate a discriminant function (DF) based on retrospectively collected data, for characterization of patients with symptomatic gallstone disease as regards presence of CBDS, and to compare clinical, ultrasonographic, and DF characterization.
Prospective registration of CBDS criteria in consecutive patients with symptomatic gallstone disease.
A department of surgical gastroenterology in a Norwegian central hospital.
One hundred ninety-two patients with gallbladder stones.
Laparoscopic cholecystectomy or ERCP with or without endoscopic sphincterotomy.
Sensitivity and specificity of the clinical, ultrasonographic, and DF characterizations, and test of the validity of the DF.
Thirty-two patients had CBDS. The clinical criteria of CBDS were present in 152 patients (79.2%): 21.1% of these patients had CBDS and there were no false-negative results (sensitivity, 100%; specificity, 25%). The risk of CBDS in patients with normal bile ducts at ultrasonographic examination was 8 of 124, and in patients with dilated ducts or suspected CBDS, 17 of 47 (sensitivity, 68%; specificity, 80%). The DF was positive in 50 patients (26%): 60% of these had CBDS, and there were 2 false-negative results (sensitivity, 94%; specificity, 88%). A discriminant analysis of the prospectively registered data selected the same set of CBDS criteria, and a new DF did not alter the characterization of any patient.
Clinical characterization had a higher sensitivity for CBDS detection than ultrasonography alone, but a lower specificity. The DF analysis was both more sensitive and specific than ultrasonography, and seemed efficient in selecting symptomatic gallstone patients for ERCP. It was reproducible and simple to use.
有症状胆结石疾病患者术前内镜逆行胰胆管造影(ERCP)的选择程序应使ERCP假阴性结果和胆总管残余结石(CBDS)的发生率都较低。
基于回顾性收集的数据验证一种判别函数(DF),用于对有症状胆结石疾病患者是否存在CBDS进行特征描述,并比较临床、超声和DF特征描述。
对连续性有症状胆结石疾病患者的CBDS标准进行前瞻性登记。
挪威一家中心医院的外科胃肠病科。
192例胆囊结石患者。
腹腔镜胆囊切除术或行或不行内镜括约肌切开术的ERCP。
临床、超声和DF特征描述的敏感性和特异性,以及DF有效性检验。
32例患者有CBDS。152例患者(79.2%)存在CBDS的临床标准:这些患者中21.1%有CBDS,且无假阴性结果(敏感性100%;特异性25%)。超声检查胆管正常的患者中CBDS风险为124例中的8例,胆管扩张或疑似CBDS的患者中为47例中的17例(敏感性68%;特异性80%)。DF在50例患者(26%)中呈阳性:其中60%有CBDS,有2例假阴性结果(敏感性94%;特异性88%)。对前瞻性登记数据的判别分析选择了相同的CBDS标准集,新的DF未改变任何患者的特征描述。
临床特征描述对CBDS检测的敏感性高于单独超声检查,但特异性较低。DF分析比超声检查更敏感且更具特异性,似乎能有效地为ERCP选择有症状胆结石患者。它具有可重复性且使用简单。